Helene Gayle - Colgate Palmolive Independent Director
| CL Stock | USD 94.87 0.62 0.66% |
Director
Dr. Helene D. Gayle, M.D, is Independent Director of ColgatePalmolive Company. Dr. Gayle has served as President and Chief Executive Officer of The Chicago Community Trust, a community foundation dedicated to improving the Chicago region through strategic grant making, civic engagement and inspiring philanthropy, since October 2017. Dr. Gayle previously served as Chief Executive Officer of McKinsey Social Initiative from 2015 to 2017 and as President and Chief Executive Officer of CARE USA from 2006 to 2015. From 2001 to 2006, she was an executive in the Global Health program at the Bill Melinda Gates Foundation. Dr. Gayle began her career in public health at the U.S. Centers for Disease Control in 1984 and held positions of increasing responsibility over her 20year tenure there, ultimately becoming the director of the National Center for HIV, STD and TB Prevention and achieving the rank of Assistant Surgeon General and Rear Admiral in the United States Public Health Service. Dr. Gayle also serves on the boards of the Center for Strategic and International Studies, the Rockefeller Foundation, New America and the Brookings Institution. She is a member of the Council on Foreign Relations, the National Academy of Medicine and the American Public Health Association. since 2010.
| Age | 64 |
| Tenure | 14 years |
| Professional Marks | Ph.D |
| Address | 300 Park Avenue, New York, NY, United States, 10022-7499 |
| Phone | 212 310 2000 |
| Web | https://www.colgatepalmolive.com |
Colgate Palmolive Management Efficiency
The company has Return on Asset (ROA) of 0.1633 % which means that for every $100 of assets, it generated a profit of $0.1633. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.4879 %, which means that it produced $0.4879 on every 100 dollars invested by current stockholders. Colgate Palmolive's management efficiency ratios could be used to measure how well Colgate Palmolive manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 3.97 this year, although the value of Return On Tangible Assets will most likely fall to 0.15. At this time, Colgate Palmolive's Intangible Assets are quite stable compared to the past year. Other Assets is expected to rise to about 1.3 B this year, although the value of Non Current Assets Total will most likely fall to about 6.7 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Nina Vaca | Cinemark Holdings | 49 | |
| Carlos Sepulveda | Cinemark Holdings | 63 | |
| Patricia Russo | Merck Company | 68 | |
| Yunus Suleman | Gold Fields Ltd | 62 | |
| Thomas Glocer | Merck Company | 61 | |
| Inge Thulin | Merck Company | 67 | |
| Nancy Loewe | Cinemark Holdings | 53 | |
| Pamela Craig | Merck Company | 64 | |
| Steven Reid | Gold Fields Ltd | 64 | |
| Enrique Hernandez | Cinemark Holdings | 76 | |
| Peter Wendell | Merck Company | 70 | |
| Christine Seidman | Merck Company | 68 | |
| Benjamin Chereskin | Cinemark Holdings | 61 | |
| Leslie Brun | Merck Company | 68 | |
| BCompt BCom | Gold Fields Ltd | 57 | |
| Alhassan Andani | Gold Fields Ltd | 58 | |
| Carmen Letton | Gold Fields Ltd | 54 | |
| Peter Bacchus | Gold Fields Ltd | 51 | |
| Paul Schmidt | Gold Fields Ltd | 52 | |
| Malcolm McAvity | Dorian LPG | 69 | |
| W Scofield | Adams Resources Energy | 66 | |
Management Performance
| Return On Equity | 0.49 | ||||
| Return On Asset | 0.16 |
Colgate Palmolive Leadership Team
Elected by the shareholders, the Colgate Palmolive's board of directors comprises two types of representatives: Colgate Palmolive inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Colgate. The board's role is to monitor Colgate Palmolive's management team and ensure that shareholders' interests are well served. Colgate Palmolive's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Colgate Palmolive's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Marsili, Senior Vice President - Global Human Resources | ||
| Philip Shotts, Principal Accounting Officer, Vice President Controller | ||
| David Foster, Chief Officer | ||
| Lorrie Norrington, Independent Director | ||
| Lauren Richardson, Chief Officer | ||
| Prabha Parameswaran, Group President Global Innovation Group and Africa-Eurasia | ||
| John Huston, Senior Vice President - Office of the Chairman | ||
| Jennifer Daniels, Chief Legal Officer and Secretary | ||
| Helene Gayle, Independent Director | ||
| John Faucher, Chief Officer | ||
| Mike Crowe, Chief Officer | ||
| Kimberly Nelson, Independent Director | ||
| Michael Polk, Independent Director | ||
| C Harris, Independent Director | ||
| Patricia Verduin, Chief Technology Officer | ||
| Gregory Malcolm, Controller VP | ||
| Paula Davis, VP Officer | ||
| Lisa Edwards, Independent Director | ||
| Valerie Haliburton, Senior Compliance | ||
| Juan Zamorano, President Division | ||
| Stephan Habif, Chief Officer | ||
| John Kooyman, Chief Marketing Officer | ||
| Stanley Sutula, Chief Financial Officer | ||
| Noel Wallace, Chairman of the Board, President, Chief Executive Officer | ||
| John Cahill, Lead Independent Director | ||
| Stephen Sadove, Lead Independent Director | ||
| Henning Jakobsen, Chief Financial Officer, Vice President, Controller | ||
| Martina HundMejean, Independent Director | ||
| Stanley III, Chief Officer | ||
| John Bilbrey, Independent Director | ||
| Panagiotis Tsourapas, Group President, Latin America, Asia Pacific & Africa-Eurasia | ||
| Sally Massey, Chief Human Resource Officer |
Colgate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Colgate Palmolive a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.49 | ||||
| Return On Asset | 0.16 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 83.93 B | ||||
| Shares Outstanding | 817.01 M | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 85.24 % | ||||
| Number Of Shares Shorted | 10.42 M | ||||
| Price To Earning | 24.43 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Colgate Palmolive. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Colgate Stock please use our How to buy in Colgate Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Household Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Colgate Palmolive. If investors know Colgate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Colgate Palmolive listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 1.96 | Earnings Share 3.48 | Revenue Per Share 24.493 | Quarterly Revenue Growth 0.024 |
The market value of Colgate Palmolive is measured differently than its book value, which is the value of Colgate that is recorded on the company's balance sheet. Investors also form their own opinion of Colgate Palmolive's value that differs from its market value or its book value, called intrinsic value, which is Colgate Palmolive's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Colgate Palmolive's market value can be influenced by many factors that don't directly affect Colgate Palmolive's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Colgate Palmolive's value and its price as these two are different measures arrived at by different means. Investors typically determine if Colgate Palmolive is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Colgate Palmolive's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.